BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35150970)

  • 1. Fatty acid nitroalkene reversal of established lung fibrosis.
    Koudelka A; Cechova V; Rojas M; Mitash N; Bondonese A; St Croix C; Ross MA; Freeman BA
    Redox Biol; 2022 Apr; 50():102226. PubMed ID: 35150970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.
    Wilkinson ML; Abramova E; Guo C; Gow JG; Murray A; Koudelka A; Cechova V; Freeman BA; Gow AJ
    Toxicol Appl Pharmacol; 2020 Nov; 407():115236. PubMed ID: 32931793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
    Kulkarni AA; Thatcher TH; Hsiao HM; Olsen KC; Kottmann RM; Morrissette J; Wright TW; Phipps RP; Sime PJ
    PLoS One; 2013; 8(5):e63798. PubMed ID: 23741300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses.
    Ambrozova G; Martiskova H; Koudelka A; Ravekes T; Rudolph TK; Klinke A; Rudolph V; Freeman BA; Woodcock SR; Kubala L; Pekarova M
    Free Radic Biol Med; 2016 Jan; 90():252-260. PubMed ID: 26620549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension.
    Klinke A; Möller A; Pekarova M; Ravekes T; Friedrichs K; Berlin M; Scheu KM; Kubala L; Kolarova H; Ambrozova G; Schermuly RT; Woodcock SR; Freeman BA; Rosenkranz S; Baldus S; Rudolph V; Rudolph TK
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):155-62. PubMed ID: 24521348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
    Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells.
    Yamada M; Kubo H; Ota C; Takahashi T; Tando Y; Suzuki T; Fujino N; Makiguchi T; Takagi K; Suzuki T; Ichinose M
    Respir Res; 2013 Sep; 14(1):95. PubMed ID: 24063588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.
    Reddy AT; Lakshmi SP; Zhang Y; Reddy RC
    FASEB J; 2014 Dec; 28(12):5299-310. PubMed ID: 25252739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.
    Kim MJ; Lee YJ; Yoon YS; Lim JH; Park EM; Chong YH; Kang JL
    Cell Physiol Biochem; 2018; 45(5):1863-1877. PubMed ID: 29510393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis.
    Semren N; Habel-Ungewitter NC; Fernandez IE; Königshoff M; Eickelberg O; Stöger T; Meiners S
    PLoS One; 2015; 10(9):e0136188. PubMed ID: 26340365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.
    Dackor RT; Cheng J; Voltz JW; Card JW; Ferguson CD; Garrett RC; Bradbury JA; DeGraff LM; Lih FB; Tomer KB; Flake GP; Travlos GS; Ramsey RW; Edin ML; Morgan DL; Zeldin DC
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L645-55. PubMed ID: 21856819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with royal jelly improves bleomycin-induced pulmonary fibrosis in rats.
    Zargar HR; Hemmati AA; Ghafourian M; Arzi A; Rezaie A; Javad-Moosavi SA
    Can J Physiol Pharmacol; 2017 Jan; 95(1):23-31. PubMed ID: 27841941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice.
    Boots AW; Veith C; Albrecht C; Bartholome R; Drittij MJ; Claessen SMH; Bast A; Rosenbruch M; Jonkers L; van Schooten FJ; Schins RPF
    BMC Pulm Med; 2020 Apr; 20(1):112. PubMed ID: 32349726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230.
    Egger C; Gérard C; Vidotto N; Accart N; Cannet C; Dunbar A; Tigani B; Piaia A; Jarai G; Jarman E; Schmid HA; Beckmann N
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(12):L1064-77. PubMed ID: 24727584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
    Su W; Wang H; Feng Z; Sun J
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.